Orthopediatrics (KIDS) Total Debt Growth (1y) (2017 - 2026)
Orthopediatrics (KIDS) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 19.06% |
| 10 | Orthopediatrics | 467.54 Mn | 453.30 Mn | 43.39 Mn | -93.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.30% |
| Dec 31, 2025 | 29.52% |
| Sep 30, 2025 | 37.69% |
| Jun 30, 2025 | -88.01% |
| Mar 31, 2025 | 584.07% |
| Dec 31, 2024 | 51,465.79% |
| Sep 30, 2024 | 9,042.25% |
| Jun 30, 2024 | 1,260.41% |
| Mar 31, 2024 | 1,213.55% |
| Dec 31, 2023 | -85.54% |
| Sep 30, 2023 | -15.07% |
| Jun 30, 2023 | -97.39% |
| Mar 31, 2023 | -13.85% |
| Dec 31, 2022 | -11.01% |
| Sep 30, 2022 | -12.62% |
| Jun 30, 2022 | 2,778.22% |
| Mar 31, 2022 | -11.55% |
| Dec 31, 2021 | 0.51% |
| Sep 30, 2021 | -10.69% |
| Jun 30, 2021 | -94.75% |